Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. - Wikidata - awgldk - TriplyDB

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

http://www.wikidata.org/entity/Q30421011

about

CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia Tracing the origin and history of the HIV-2 epidemic HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies Integrated analysis of residue coevolution and protein structures capture key protein sectors in HIV-1 proteins Current status of HIV/AIDS in Cameroon: how effective are control strategies?Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database Highly sensitive method for amplification of human immunodeficiency virus type 2 DNA.Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4⁺ cell counts Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry.Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.The HIV oligonucleotide database (HIVoligoDB).HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal Detection of simian immunodeficiency virus in diverse species and of human immunodeficiency virus Type 2 by using consensus primers within the pol region Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx).Human immunodeficiency viruses and drug therapy: resistance and implications for antiretroviral therapy.Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal.Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners.Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors Fecal viral load and norovirus-associated gastroenteritis.The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform.Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology HIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine Development Virological Characterization of Dual HIV-1/HIV-2 Seropositivity and Infections in Southern Ghana Retrospective study of maternal HIV-1 and HIV-2 infections and child survival in Abidjan, Côte d'Ivoire.Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1.Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding.Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2.

P2860

Q24557545-BF0063B7-00C2-4482-A703-736439615EF3 Q24671064-AE173D5D-6592-403E-B5AD-2DE38F7C8ADC Q28291024-6F7AADE3-B81F-4ABA-A464-5B8737A3BBC8 Q28307869-1917696C-4E51-470C-A2FC-DB1E1F336634 Q28543396-9C4D26F5-2388-4D75-83F6-EC2CEF15C81D Q30374425-90EDDF46-AA37-437E-AC74-8101B3A4345C Q30417537-12E1678F-0535-4985-AF1E-A891D8BCFB72 Q33321434-65413B9C-EDD8-4EC7-A549-8F954B50F399 Q33660110-D9AD4AA3-D633-45C8-85F7-F30FCE576DEC Q33670735-DB9B5F8B-3E30-4740-B6CD-A1D6DEE89A20 Q33705170-06B33B66-A68E-442A-AF9B-16ECAE91948D Q33780668-AC00B7D2-30D3-4FFA-95FF-71913FFC414A Q33784897-D6AB2FBF-8E9A-438C-A8FC-D215AD547F74 Q33787066-462B7BDF-E94B-4C72-90BC-1D012DEE993A Q33886389-785E7FED-B3F1-479D-B447-29AA64A0152B Q33963958-5C98A2E5-90DC-4D79-8DBF-5CBCEFA52166 Q34080828-6D6A8BF1-FFFF-426A-AFEC-0BE3C25786C9 Q34195438-DC80FFB0-95CD-48D8-B690-346B0F951544 Q34545626-DF80DB48-2953-41D6-9AB0-2B3D8BBBB171 Q34639729-7A333551-0473-41F8-8153-D48960A4A74B Q34793224-5A5280EF-C33F-40DD-8DD2-6E6DF577DFE7 Q35529313-F8A9E027-6C75-4A8F-BCFD-51BE5412D9B2 Q35562573-B0ACA008-4954-4A2F-B437-75A1D091A95B Q35636029-D900179A-CBDA-4E80-8144-9BF8944F7369 Q35793225-C1096CD0-8FD1-43A7-9361-4B24A6B0FAC7 Q35844702-E1EB9B74-52DB-4EFC-A9E0-A4548DAD2A82 Q35859611-0E250E25-4E3D-47A9-B5C0-C9704824D18E Q35883837-9C44D68A-FEB5-4A87-916E-ED2E43EBEDA3 Q36239297-20DD4FB9-5D93-4D31-A8D6-D20148F50DAE Q36239954-CC939D61-7B51-49D4-BC5F-07F2193BAB9D Q36631349-0A74E37F-2EF0-4C6D-BF67-E989F6129558 Q36637244-0B6EF076-E4C1-4E0D-A9A6-344302E2596C Q36651031-B4511689-88AD-438D-BBA0-D334AD616D53 Q36711397-FBC7164D-775B-4D2C-870B-7B273075619B Q36884349-816F9CF7-28B4-432D-93BC-083E5A4FC4BD Q36897863-A62396BC-A1A2-4E8E-AFBA-E16E21F54D75 Q37052996-F2AADE4B-F60C-4390-85AE-23B095C35B5F Q37053007-49129FE3-EF90-4067-8F1B-55725C1FA857 Q37053027-5D80B703-A146-4803-8825-32CAA8227FD2 Q37072022-2D17E07D-B29F-42E8-9EF0-42FFBE1B1F96

P2860

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

http://www.wikidata.org/entity/Q30421011

description

1993 nî lūn-bûn

@nan

1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

@ast

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

@en

type

label

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

@ast

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

@en

prefLabel

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

@ast

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

@en

P1433

Q30421011-73AFC0D8-337E-4CE2-8C9D-E487AF779BCB

P1476

Q30421011-557CA252-BBB7-4EBD-A3EE-BF8EAC369EA4

P2093

Q30421011-52BEA4A5-0DE4-4E57-B7D1-9C94EFAE7A2E

Q30421011-66C8F4C6-2600-45BA-BD8F-39F8BBFC10C6

Q30421011-6B8702B5-E432-43B9-84AE-B91D573AFF86

Q30421011-78364011-B25E-47E4-BE0C-2D3F414F8963

Q30421011-7AF3E793-5828-4BC9-ACA0-A1623F8744B7

Q30421011-80DFBDF2-B92B-4DAD-AF65-1821B3F283E9

Q30421011-A0613177-1274-450F-A1AF-DC8EEFE4B8E4

Q30421011-CAA4AC0C-5C66-4F8C-8BC8-927A9D482730

Q30421011-CAEAB53C-851B-4E5B-9C23-F148AF761F51

Q30421011-F4E7C270-4C97-41EB-93B0-D11B98637E0F

P304

Q30421011-AEC9A665-6476-4B8A-8F6D-77508D0DA0B4

P31

Q30421011-8D452EF2-502D-44D6-BCF2-3CAE115D8C72

P356

Q30421011-9689A7CF-3B4C-4CFE-9C76-1F17AFF486B4

P407

Q30421011-82DDA1D6-E23E-45E4-A5F0-72AF89D1199A

P433

Q30421011-B6FE2467-AC3D-4B01-B19B-693715725DD5

P478

Q30421011-266C7227-65C4-48D4-8C1C-F4CC498214E2

P577

Q30421011-E3045142-1696-4D64-8725-EC3EDCF0879E

P698

Q30421011-B4B82E4B-3D85-47EE-82DC-9FA0A3AD5A86

P921

Q30421011-339DF4BA-806A-4BEE-83A4-617202EE9D84

Q30421011-C78994C3-6BC4-4677-B0D5-A0FB92A10872

P356

JAMA.270.17.2083

P1433

Journal of the American Medical Association

P1476

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

@en

P2093

E Ekpini

http://www.w3.org/2001/XMLSchema#string

G Adjorlolo

http://www.w3.org/2001/XMLSchema#string

H D Gayle

http://www.w3.org/2001/XMLSchema#string

J Kouadio

http://www.w3.org/2001/XMLSchema#string

K Brattegaard

http://www.w3.org/2001/XMLSchema#string

K M De Cock

http://www.w3.org/2001/XMLSchema#string

K M Vetter

http://www.w3.org/2001/XMLSchema#string

M Maran

http://www.w3.org/2001/XMLSchema#string

R Doorly

http://www.w3.org/2001/XMLSchema#string

T Sibailly

http://www.w3.org/2001/XMLSchema#string

P304

2083-2086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.270.17.2083

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

270

http://www.w3.org/2001/XMLSchema#string

P577

1993-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8147962

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission